Familial pemphigus vulgaris: Immunogenetic study of HLA class II antigens;Pénfigo vulgar familiar: Estudio inmunogenético de los antígenos HLA clase II

Actas Dermo-Sifiliograficas

Volumn 97, Issue 8, 2006, Pages 509-513

  Bordel Gómez, Ma Teresa ^a   Sánchez Estella, Juan ^a   Yuste Chaves, Manuela ^a   Santos Durán, Juan Carlos ^a   Pablo, Ma Teresa Alonso San ^a  

^a Hospital Provincial de Zamora   (Spain)

Author keywords

Familial pemphigus vulgaris; HLA class II alleles; HLA DR14; HLA DR4; Pemphigus vulgaris

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR4 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; HAPLOTYPE; HUMAN; MALE; PEMPHIGUS VULGARIS; POLYMERASE CHAIN REACTION; SIBLING; SIBLING RELATION;

EID: 33845269814     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(06)73452-4     Document Type: Article

References (25)

1. Miyagawa S, Niizeki H, Yamashina Y, Kaneshige T. Genotyping for HLA-A, B and C alleles in Japanese patients with pemphigus: prevalence of Asian alleles of the HLA-B15 family. Br J Dermatol. 2002;146:52-8.
2. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991;67:869-77.
3. Amagai M, Koch PJ, Nishikawa T, Stanley JR. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invet Dermatol. 1996;106:351-5.
4. Amagai M, Ishii K, Takayanagui A, Shimizu J. Transport to endoplasmic reticulum by signal peptide, but not proteolytic processing, is required for formation of conformational epitopes of Pemphigus vulgaris antigen (desmoglein). J Invest Dermatol. 1996;107:539-42.
5. Turner MS, Sutton D, Sander DN. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris J Am Acad Dermatol. 2000;43:1053-64.
6. Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet. 1999;354:667-72.
7. Udey MC, Stanley JR. Pemphigus-diseases of antidesmosomal autoimmunity. JAMA. 1999;282:572-6.
8. Miyagawa S, Higashimine I, Iida T, Yamashina Y, Fukumoto T, Shirai T. HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese. J Invest Dermatol. 1997;109:615-8.
9. Carcasi C, Cottoni F, Floris L, Vacca A, Mulargia M, Arras M, et al. HLA haplotypes and class II molecular alleles in sardinian and italian patients with pemphigus vulgaris. Tissue Antigens. 1996;48:662-7.
10. González-Escribano MF, Jiménez G, Walter K, Montes M, Pérez-Bernal AM, Rodríguez MR, et al. Distribution of HLA class II alleles among Spanish patients with pemphigus vulgaris. Tissue Antigens. 1998;52:275-8.
11. Pisanti S, Sharav Y, Kaufman E, Posner LM. Pemphigus vulgaris: Incidence in Jews of different ethnic groups according to age, sex and initial lesion. Oral Surg Oral Med Oral Pathol. 1974;38:382-7.
12. Becker BA, Gaspari AA. Pemphigus vulgaris and vegetans. Dermatol Clin. 1993;11:429-52.
13. Ahmed AR, Yunis EJ, Khatri K, Wagner R, Notani G, Awdeh Z, et al. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA. 1990;87:7658-62.
14. Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, et al. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA. 1995;92:11935-9.
15. Lombardi ML, Mercuro O, Ruocco V, Lo Schiavo A, Lombardi V, Guerrera V, et al. Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients. J Invest Dermatol. 1999;113:107-10.
16. Delgado JC, Yunis DE, Bozon M, Salazar R, Deulofeut D, Turbay NK, et al. MHC class II alleles and haplotypes in patients with pemphigus vulgaris from India. Tissue Antigens. 1996;48:668-72.
17. Hertl M, Amagai M, Sundaram H, Stanley J, Ishii K, Katz SI. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J Invest Dermatol. 1998;110:62-6.
18. Starzycki Z, Chorzelski TP, Jablonska S. Familial pemphigus vulgaris in mother and daughter. Int J Dermatol. 1998;37:211-4.
19. Kricheli D, Frusic-Zlotkin M, Goldsmith D, Rabinov M, Sulkes J, Milner Y. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br J Dermatol. 2000;143:337-42.
20. Feinstein A, Yorav S, Movshovitz M, Schewach-Millet M. Pemphigus in families. Int J Dermatol. 1991;30:347-51.
21. Matzner Y, Erlich HA, Brautbar C, Sanilevitch A, Landau M, Brenner S, et al. Identical HLA class II alleles predispose to drug triggered and idiophatic pemphigus vulgaris. Acta Derm Veneorol. 1995;75:12-4.
22. Ahmed AR, Park MS, Tiwari JL, Terasaki PI. Association of DR4 with pemphigus. Exp Clin Immunogenet. 1987;4:8-16.
23. Ahmed AR, Wagner R, Khatri K, Notani G, Awdeh Z, Alper CA, et al. Major histocompatibility complex haplotype and class II genes in non jewish patients with pemphigus vulgaris. Proc Natl Acad Sci. 1991;88:5056-60.
24. Ahmed AR, Mohimen A, Yunis EJ, Mirza NM, Kumar V, Beutner EH, et al. Linkage of pemphigus vulgaris antibody to the Major Histocompatibility Complex in healthy relatives of patients. J Exp Med. 1993;177:419-24.
25. Tur E, Brenner S. Diet and pemphigus. In pursuit of exogenous factors in pemphigus and fogo selvagem. Arch Dermatol. 1998;134:1406-10.